Emerging agenda for our next meeting: Spring, 2017

  • Smart strategy: Strategic labeling and Local level labeling intelligence
  • Smart resourcing: current and future labeling roles; Resourcing through the lifecycle; Outsourcing/ Offshoring
  • Smart management: Labeling across sectors; E2E process back –end best practice
  • Smart technology: key IT solutions for labeling and RIM

The network for Labelling professionals of life science companies

Established in 2011, labelnet provides a neutral platform for Heads of Labelling and labelling professionals to network, share insights and experiences, benchmark performance, develop best practices across the full lifecycle of labelling, from the definition of company positions (CCDS, CCSI) to local/regional labelling (SmPC, USPI, reference labels, etc.) and, ultimately, to label implementation (artwork, packaging, and electronic media).

In light of the increasingly pivotal role labelling plays in improving patient safety and as a key channel for Benefit-Risk communications, together with the increasing emphasis regulators place on labelling as an integral part of a PV system, we aim to develop compelling, yet practical solutions to meet ever shifting regulatory requirements, whilst providing business value and meeting the needs of patients and prescribers. The philosophy behind labelnet is to:

  • Provide a platform for industry peers to network,  share  and learn from one another in an secure yet open environment
  • Deliver benchmark information to compare and measure operational and organisational performance
  • Identify key issues facing labelling organisations with “hot topics” addressed by action teams
  • Create a network to develop best practices to define the future of labelling
  • Provide access to the latest labelling insights through forums,  working groups, webcasts, and community exchanges

Latest insights in the labelling space

  • The Company Core Datasheet (CCDS) is an essential document for global label management, particularly in upholding label consistencies across diverse markets.  Clearly defined processes for the creation, update and version management of the CCDS, alongside a clear policy for regional/local implementation, are required to ensure that accurate and consistent benefit-risk information is communicated to the end-users in an effective and timely manner.
  • The need to have End-to-End labelling oversight is now a regulatory expectation and no longer just a future requirement.  End-to-End tracking of status and timelines is an essential part of enabling End-to-End labelling oversight i.e. from confirmation of safety signal to label implementation ‘in pack’.
  • Effective management and governance of local label deviations drive global consistency of messages and provide oversight and assurance of labelling compliance in the global operating environment.
  • A proactive labelling intelligence strategy will become increasingly important in enabling companies to adapt and respond to the rapidly changing regulatory environment and the growing presence and importance of emerging markets.
  • The focus for labelling of the future will shift from simply “staying compliant” to improving operational efficiency and adding value, via deployment of new technologies tailored to the needs of labelling, new paradigms in managing product information/label content (e.g. structured content, IDMP),  and smart applications of labelling (e.g. eLabelling).

Member Benefits

pvnet member Raise the profile of your company and your team The facilitation of strategic thinking A quantitative and qualitative performance benchmark The bringing to life of best practice

For further information, or to register your interest, please contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

  • All
  • AMS
  • BI
  • Brochure
  • CaseStudy
  • Clinical
  • CMS
  • MedicalDevices
  • On DemandWebinar
  • Quality
  • Regulatory
  • Safety
  • Technology
  • Whitepaper

Latest News

09
Jun2017

Life Sciences expert Navitas augments end-to-end capabilities

Navitas, a technology-led Life Sciences services provider across Clinical, Regulatory and Safety, announced that...

20
Apr2017

ICH Reflection on “GCP Renovation”: Modernization of ICH E8 and...

Navitas Life Sciences welcomes the opportunity to provide comments on this Reflection Paper... Navitas Life...